Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): Uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria

Journal of Leukocyte Biology

Volumn 80, Issue 4, 2006, Pages 774-786

  Nasr, Abdelhakim Ben ^a   Haithcoat, Judith ^a   Masterson, Joseph E ^a   Gunn, John S ^b   Eaves Pyles, Tonyia ^a   Klimpel, Gary R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Bacterial infection; Cytokines; Innate immunity; Lipopolysacchiride; LPS

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; COMPLEMENT RECEPTOR 4; CYTOKINE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OPSONIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FRANCISELLA TULARENSIS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MACROPHAGE FUNCTION; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TULAREMIA; UPREGULATION;

BACTERIAL VACCINES; CYTOKINES; DENDRITIC CELLS; FRANCISELLA TULARENSIS; HUMANS; INTEGRIN ALPHAXBETA2; MACROPHAGE-1 ANTIGEN; OPSONIN PROTEINS; PHAGOCYTOSIS; UP-REGULATION;

BACTERIA (MICROORGANISMS); FRANCISELLA; FRANCISELLA TULARENSIS;

EID: 33751511700     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1205755     Document Type: Article

References (77)

1. Tarnvik, A., Ericsson, M., Golovliov, I., Sandstrom, G., Sjostedt, A. (1996) Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol. Med. Microbiol. 13, 221-225.
2. Sandstrom, G., Sjostedt, A., Tarnvik, A. (1996) The first international conference on tularemia: Umea, Sweden, 23-25 August 1995 - introduction. FEMS Immunol. Med. Microbiol. 13, 179.
3. Jacobs, R. F. (1996) Tularemia. Adv. Pediatr. Infect. Dis. 12, 55-69.
4. Titball, R. W., Sjostedt, A. (2003) Francisella tularensis: an overview. ASM News 69, 558-563.
5. Jantzen, E., Berdal, B. P., Omland, T. (1979) Cellular fatty acid composition of Francisella tularensis. J. Clin. Microbiol. 10, 928-930.
6. Nichols, P. D., Mayberry, W. R., Antworth, C. P., White, D. C. (1985) Determination of monounsaturated double-bond position and geometry in the cellular fatty acids of the pathogenic bacterium Francisella tularensis. J. Clin. Microbiol. 21, 738-740.
7. Hood, A. M. (1977) Virulence factors of Francisella tularensis. J. Hyg. (Lond.) 79, 47-60.
8. Ancuta, P., Pedron, T., Girard, R., Sandstrom, G., Chaby, R. (1996) Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64, 2041-2046.
9. Dreisbach, V. C., Cowley, S., Elkins, K. L. (2000) Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and γ interferon. Infect. Immun. 68, 1988-1996.
10. Sandstrom, G., Sjostedt, A., Johansson, T., Kuoppa, K., Williams, J. C. (1992) Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 5, 201-210.
11. Skrodzki, E., Roszkiewicz, A. (1968) Investigations on the pathogenesis of tularemia. 8. Histopatological changes in the organs of white mice due to the effect of F. tularensis endotoxin. Biul. Inst. Med. Morsk. Gdansk. 19, 77-84.
12. Forsman, M., Sandstrom, G., Sjostedt, A. (1994) Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int. J. Syst. Bacteriol. 44, 38-46.
13. Svensson, K., Larsson, P., Johansson, D., Bystrom, M., Forsman, M., Johansson, A. (2005) Evolution of subspecies of Francisella tularensis. J. Bacteriol. 187, 3903-3908.
14. Tarnvik, A. (1989) Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11, 440-451.
15. Sjostedt, A., Tarnvik, A., Sandstrom, G. (1996) Francisella tularensis: host-parasite interaction. FEMS Immunol. Med. Microbiol. 13, 181-184.
16. Larsson, P., Oyston, P. C., Chain, P., Chu, M. C., Duffield, M., Fuxelius, H. H., Garcia, E., Halltorp, G., Johansson, D., Isherwood, K. E., et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37, 153-159.
17. Oyston, P. C., Sjostedt, A., Titball, R. W. (2004) Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat. Rev. Microbiol. 2, 967-978.
18. Dennis, D. T., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Friedlander, A. M., Hauer, J., Layton, M., et al. (2001) Tularemia as a biological weapon: medical and public health management. JAMA 285, 2763-2773.
19. Nano, F. E., Zhang, N., Cowley, S. C., Klose, K. E., Cheung, K. K., Roberts, M. J., Ludu, J. S., Letendre, G. W., Meierovics, A. I., Stephens, G., Elkins, K. L. (2004) A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186, 6430-6436.
20. Conlan, J. W., Sjostedt, A., North, R. J. (1994) CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect. Immun. 62, 5603-5607.
21. Stenmark, S., Sunnemark, D., Bucht, A., Sjostedt, A. (1999) Rapid local expression of interleukin-12, tumor necrosis factor α, and γ interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect. Immun. 67, 1789-1797.
22. Sjostedt, A., Conlan, J. W., North, R. J. (1994) Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62, 2779-2783.
23. Cowley, S. C., Elkins, K. L. (2003) Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon γ receptors. J. Exp. Med. 198, 379-389.
24. Elkins, K. L., Cowley, S. C., Bosio, C. M. (2003) Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5, 135-142.
25. Fulop, M., Mastroeni, P., Green, M., Titball, R. W. (2001) Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19, 4465-4472.
26. Telepnev, M., Golovliov, I., Grundstrom, T., Tarnvik, A., Sjostedt, A. (2003) Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signaling and secretion of TNF-α and IL-1 from murine macrophages. Cell. Microbiol. 5, 41-51.
27. Fortier, A. H., Polsinelli, T., Green, S. J., Nacy, C. A. (1992) Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60, 817-825.
28. Elkins, K. L., Rhinehart-Jones, T., Nacy, C. A., Winegar, R. K., Fortier, A. H. (1993) T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61, 823-829.
29. Elkins, K. L., Leiby, D. A., Winegar, R. K., Nacy, C. A., Fortier, A. H. (1992) Rapid generation of specific protective immunity to Francisella tularensis. Infect. Immun. 60, 4571-4577.
30. Anthony, L. S., Ghadirian, E., Nestel, F. P., Kongshavn, P. A. (1989) The requirement for γ interferon in resistance of mice to experimental tularemia. Microb. Pathog. 7, 421-428.
31. Bosio, C. M., Dow, S. W. (2005) Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175, 6792-6801.
32. Katz, J., Zhang, P., Martin, M., Vogel, S. N., Michalek, S. M. (2006) Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect. Immun. 74, 2809-2816.
33. Clemens, D. L., Lee, B. Y., Horwitz, M. A. (2005) Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect. Immun. 73, 5892-5902.
34. Clemens, D. L., Lee, B. Y., Horwitz, M. A. (2004) Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72, 3204-3217.
35. Bolger, C. E., Forestal, C. A., Italo, J. K., Benach, J. L., Furie, M. B. (2005) The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines. J. Leukoc. Biol. 77, 893-897.
36. Lofgren, S., Tarnvik, A., Bloom, G. D., Sjoberg, W. (1983) Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect. Immun. 39, 715-720.
37. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
38. Cowley, S. C., Hamilton, E., Frelinger, J. A., Su, J., Forman, J., Elkins, K. L. (2005) CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J. Exp. Med. 202, 309-319.
39. Ardavin, C., Amigorena, S., Reis e Sousa, C. (2004) Dendritic cells: immunobiology and cancer immunotherapy. Immunity 20, 17-23.
40. Weineisen, M., Sjoring, U., Fallman, M., Andersson, T. (2004) Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling. J. Immunol. 172, 3798-3807.
41. Schlesinger, L. S., Horwitz, M. A. (1991) Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147, 1983-1994.
42. Schlesinger, L. S., Horwitz, M. A. (1990) Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J. Clin. Invest. 85, 1304-1314.
43. Schlesinger, L. S., Bellinger-Kawahara, C. G., Payne, N. R., Horwitz, M. A. (1990) Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144, 2771-2780.
44. Zimmerli, S., Edwards, S., Ernst, J. D. (1996) Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am. J. Respir. Cell Mol. Biol. 15, 760-770.
45. Ernst, J. D. (2000) Bacterial inhibition of phagocytosis. Cell. Microbiol. 2, 379-386.
46. Schlesinger, L. S. (1993) Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150, 2920-2930.
47. Kieffer, T. L., Cowley, S., Nano, F. E., Elkins, K. L. (2003) Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 5, 397-403.
48. Cowley, S. C., Myltseva, S. V., Nano, F. E. (1996) Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20, 867-874.
49. Tseng, C. T., Klimpel, G. R. (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43-49.
50. Tseng, C. T., Miskovsky, E., Klimpel, G. R. (2001) Crosslinking CD81 results in activation of TCRγδ T cells. Cell. Immunol. 207, 19-27.
51. Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R., Liu, Y. J. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186.
52. Kolb-Maurer, A., Gentschev, I., Fries, H. W., Fiedler, F., Brocker, E. B., Kampgen, E., Goebel, W. (2000) Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect. Immun. 68, 3680-3688.
53. Giacomini, E., Iona, E., Ferroni, L., Miettinen, M., Fattorini, L., Orefici, G., Julkunen, I., Coccia, E. M. (2001) Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166, 7033-7041.
54. Dixon, G. L., Newton, P. J., Chain, B. M., Katz, D., Andersen, S. R., Wong, S., van der Ley, P., Klein, N., Callard, R. E. (2001) Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect. Immun. 69, 4351-4357.
55. Subauste, C. S., Wessendarp, M. (2000) Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J. Immunol. 165, 1498-1505.
56. Newman, S. L., Holly, A. (2001) Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect. Immun. 69, 6813-6822.
57. Kelly, R. M., Chen, J., Yauch, L. E., Levitz, S. M. (2005) Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans. Infect. Immun. 73, 592-598.
58. Fortsch, D., Rollinghoff, M., Stenger, S. (2000) IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165, 978-987.
59. Kolb-Maurer, A., Kurzai, O., Goebel, W., Frosch, M. (2003) The role of human dendritic cells in meningococcal and listerial meningitis. Int. J. Med. Microbiol. 293, 241-249.
60. Nagl, M., Kacani, L., Mullauer, B., Lemberger, E. M., Stoiber, H., Sprinzl, G. M., Schennach, H., Dierich, M. P. (2002) Phagocytosis and killing of bacteria by professional phagocytes and dendritic cells. Clin. Diagn. Lab. Immunol. 9, 1165-1168.
61. Van Overtvelt, L., Vanderheyde, N., Verhasselt, V., Ismaili, J., De Vos, L., Goldman, M., Willems, F., Vray, B. (1999) Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect. Immun. 67, 4033-4040.
62. Huang, Q., Liu, D., Majewski, P., Schulte, L. C., Korn, J. M., Young, R. A., Lander, E. S., Hacohen, N. (2001) The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870-875.
63. Gavrilin, M. A., Bouakl, I. J., Knatz, N. L., Duncan, M. D., Hall, M. W., Gunn, J. S., Wewers, M. D. (2006) Internalization and phagosome escape required for Francisella to induce human monocyte IL-1β processing and release. Proc. Natl. Acad. Sci. USA 103, 141-146.
64. Hornef, M. W., Wick, M. J., Rhen, M., Normark, S. (2002) Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 3, 1033-1040.
65. Sundquist, M., Wick, M. J. (2005) TNF-α-dependent and -independent maturation of dendritic cells and recruited CD11(int)CD11b(+) cells during oral Salmonella infection. J. Immunol. 175, 3287-3298.
66. Sundquist, M., Rydstrom, A., Wick, M. J. (2004) Immunity to Salmonella from a dendritic point of view. Cell. Microbiol. 6, 1-11.
67. Buelens, C., De Groote, D., Goldman, M., Willems, F. (1996) Differential effects of interleukin-10 on the production of interleukin-12 and interleukin-8 by human dendritic cells generated from peripheral blood. Transplant. Proc. 28, 3255-3256.
68. Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M., Willems, F. (1997) Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol. 27, 1848-1852.
69. Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M., Willems, F. (1997) Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27, 756-762.
70. McGuirk, P., McCann, C., Mills, K. H. (2002) Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221-231.
71. Akbari, O., DeKruyff, R. H., Umetsu, D. T. (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2, 725-731.
72. Sing, A., Roggenkamp, A., Geiger, A. M., Heesemann, J. (2002) Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168, 1315-1321.
73. Forestal, C. A., Benach, J. L., Carbonara, C., Italo, J. K., Lisinski, T. J., Furie, M. B. (2003) Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J. Immunol. 171, 2563-2570.
74. Lai, X. H., Golovliov, I., Sjostedt, A. (2004) Expression of IglC is necessary for intracellular growth and induction of apoptosis in murine macrophages by Francisella tularensis. Microb. Pathog. 37, 225-230.
75. Mariathasan, S., Weiss, D. S., Dixit, V. M., Monack, D. M. (2005) Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202, 1043-1049.
76. Santic, M., Molmeret, M., Abu Kwaik, Y. (2005) Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-γ. Cell. Microbiol. 7, 957-967.
77. Santic, M., Molmeret, M., Klose, K. E., Jones, S., Kwaik, Y. A. (2005) The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm. Cell. Microbiol. 7, 969-979.